Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Pioglitazone on Exogenous Carbohydrate Oxidation During Exercise at High Altitude
NCT06164665Phase 4Completed
- Sponsor
- U.S. Army Research Institute of Environmental Medicine
- Start
- Mar 2023
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pioglitazone in acute mountain sickness (AMS), sponsored by U.S. Army Research Institute of Environmental Medicine. Started Mar 2023; status: completed.
02
Drugs
pioglitazone
03
Conditions
acute mountain sickness (AMS)
Beyond the preview
Go deeper on NCT06164665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06164665.